Reintroduction of SALSA Revives Labs’ Hopes for PAMA Relief
New legislation would force CMS to change the way it calculates Medicare prices for lab tests.
No Surprises Act Independent Dispute Resolution Process Resumes
HHS orders arbitrators to go back to resolving payment disputes between providers and payors under the No Surprises Act.
Medicare to Pay for 22 Additional PLA Codes, Starting April 1
To ensure proper Medicare Part B billing and coding, your billing staff must be aware of all 22 of the newly recognized PLA codes.
Already a member? Log in here
CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
Already a member? Log in here
Labs Should Be Wary of Improper Billing of G0483 Testing
Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.